Page last updated: 2024-10-27

flutamide and Leukemia, Erythroblastic, Acute

flutamide has been researched along with Leukemia, Erythroblastic, Acute in 2 studies

Flutamide: An antiandrogen with about the same potency as cyproterone in rodent and canine species.

Leukemia, Erythroblastic, Acute: A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.

Research Excerpts

ExcerptRelevanceReference
"Treatment with androstenedione (500nM) significantly (p<0."1.29Androstenedione increases thromboxane A2 receptors in human erythroleukemia cells. ( Halushka, PV; Higashiura, K; Mathur, RS; Zucker, TP, 1996)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ajayi, AA1
Matsuda, K1
Schrör, K1
Masuda, A1
Mathur, R1
Halushka, PV2
Zucker, TP1
Higashiura, K1
Mathur, RS1

Other Studies

2 other studies available for flutamide and Leukemia, Erythroblastic, Acute

ArticleYear
Androgen regulation of thromboxane A2 receptors.
    Advances in prostaglandin, thromboxane, and leukotriene research, 1995, Volume: 23

    Topics: Animals; Aorta; Blood Platelets; Cells, Cultured; Estradiol; Flutamide; Humans; Kinetics; Leukemia,

1995
Androstenedione increases thromboxane A2 receptors in human erythroleukemia cells.
    Life sciences, 1996, Volume: 58, Issue:8

    Topics: Androgen Antagonists; Androstenedione; Animals; Aorta; Bridged Bicyclo Compounds, Heterocyclic; Carb

1996